426 related articles for article (PubMed ID: 32640967)
1. Autoimmune Encephalitis: Current Knowledge on Subtypes, Disease Mechanisms and Treatment.
Nissen MS; Ryding M; Meyer M; Blaabjerg M
CNS Neurol Disord Drug Targets; 2020; 19(8):584-598. PubMed ID: 32640967
[TBL] [Abstract][Full Text] [Related]
2. Glutamate receptor antibodies in neurological diseases: anti-AMPA-GluR3 antibodies, anti-NMDA-NR1 antibodies, anti-NMDA-NR2A/B antibodies, anti-mGluR1 antibodies or anti-mGluR5 antibodies are present in subpopulations of patients with either: epilepsy, encephalitis, cerebellar ataxia, systemic lupus erythematosus (SLE) and neuropsychiatric SLE, Sjogren's syndrome, schizophrenia, mania or stroke. These autoimmune anti-glutamate receptor antibodies can bind neurons in few brain regions, activate glutamate receptors, decrease glutamate receptor's expression, impair glutamate-induced signaling and function, activate blood brain barrier endothelial cells, kill neurons, damage the brain, induce behavioral/psychiatric/cognitive abnormalities and ataxia in animal models, and can be removed or silenced in some patients by immunotherapy.
Levite M
J Neural Transm (Vienna); 2014 Aug; 121(8):1029-75. PubMed ID: 25081016
[TBL] [Abstract][Full Text] [Related]
3. Immunopathology of autoantibody-associated encephalitides: clues for pathogenesis.
Bien CG; Vincent A; Barnett MH; Becker AJ; Blümcke I; Graus F; Jellinger KA; Reuss DE; Ribalta T; Schlegel J; Sutton I; Lassmann H; Bauer J
Brain; 2012 May; 135(Pt 5):1622-38. PubMed ID: 22539258
[TBL] [Abstract][Full Text] [Related]
4. [Limbic encephalitis: the new cell membrane antigens and a proposal of clinical-immunological classification with therapeutic implications].
Dalmau J; Bataller L
Neurologia; 2007 Oct; 22(8):526-37. PubMed ID: 18000762
[TBL] [Abstract][Full Text] [Related]
5. General features, pathogenesis, and laboratory diagnostics of autoimmune encephalitis.
Masciocchi S; Businaro P; Scaranzin S; Morandi C; Franciotta D; Gastaldi M
Crit Rev Clin Lab Sci; 2024 Jan; 61(1):45-69. PubMed ID: 37777038
[TBL] [Abstract][Full Text] [Related]
6. Autoimmune Epilepsy.
Gaspard N
Continuum (Minneap Minn); 2016 Feb; 22(1 Epilepsy):227-45. PubMed ID: 26844739
[TBL] [Abstract][Full Text] [Related]
7. [An Update on Therapeutic Management in Autoimmune Encephalitis].
Kamei S
Brain Nerve; 2023 May; 75(5):479-484. PubMed ID: 37194516
[TBL] [Abstract][Full Text] [Related]
8. Autoimmune encephalitis : Part 1 (Epidemiology, Pathophysiology and Clinical spectrum).
Hiesgen J; Schutte C
S Afr Med J; 2023 Mar; 113(3):116-121. PubMed ID: 36876355
[TBL] [Abstract][Full Text] [Related]
9. [Neurological syndromes, encephalitis].
Yamamoto T; Tsuji S
Gan To Kagaku Ryoho; 2010 Jun; 37(6):995-1005. PubMed ID: 20567100
[TBL] [Abstract][Full Text] [Related]
10. Glutamate Receptor Antibodies in Autoimmune Central Nervous System Disease: Basic Mechanisms, Clinical Features, and Antibody Detection.
Scotton WJ; Karim A; Jacob S
Methods Mol Biol; 2019; 1941():225-255. PubMed ID: 30707437
[TBL] [Abstract][Full Text] [Related]
11. Neuroimmunological antibody-mediated encephalitis and implications for diagnosis and therapy in neuropsychiatry.
Marinas JE; Matveychuk D; Dursun SM; Baker GB
Acta Neuropsychiatr; 2020 Aug; 32(4):177-185. PubMed ID: 31791436
[TBL] [Abstract][Full Text] [Related]
12. Anti-NMDA-receptor encephalitis: case series and analysis of the effects of antibodies.
Dalmau J; Gleichman AJ; Hughes EG; Rossi JE; Peng X; Lai M; Dessain SK; Rosenfeld MR; Balice-Gordon R; Lynch DR
Lancet Neurol; 2008 Dec; 7(12):1091-8. PubMed ID: 18851928
[TBL] [Abstract][Full Text] [Related]
13. Autoimmune encephalopathies.
Leypoldt F; Armangue T; Dalmau J
Ann N Y Acad Sci; 2015 Mar; 1338(1):94-114. PubMed ID: 25315420
[TBL] [Abstract][Full Text] [Related]
14. Autoimmune epilepsy in children: case series and proposed guidelines for identification.
Suleiman J; Brilot F; Lang B; Vincent A; Dale RC
Epilepsia; 2013 Jun; 54(6):1036-45. PubMed ID: 23551014
[TBL] [Abstract][Full Text] [Related]
15. Anti-NMDAR autoimmune encephalitis.
Miya K; Takahashi Y; Mori H
Brain Dev; 2014 Sep; 36(8):645-52. PubMed ID: 24211006
[TBL] [Abstract][Full Text] [Related]
16. [Autoimmune synaptic encephalitis is a disease entity on the rise].
Modvig S; Høi-Hansen CE; Uldall P; Somnier F
Ugeskr Laeger; 2012 May; 174(21):1452-6. PubMed ID: 22640785
[TBL] [Abstract][Full Text] [Related]
17. Neurological syndromes and potential triggers associated with antibodies to neuronal surface antigens.
Klein da Costa B; de Oliveira Pinto P; Staub L; Hansel G; Vanik Pinto G; Porcello Schilling L; Rodrigues Dos Passos G; Alves Martins W; Becker J; Machado Castilhos R; Palmini A; Sato DK
Mult Scler Relat Disord; 2023 Dec; 80():105022. PubMed ID: 37864878
[TBL] [Abstract][Full Text] [Related]
18. Neuronal surface antibody-mediated autoimmune encephalitis.
Linnoila JJ; Rosenfeld MR; Dalmau J
Semin Neurol; 2014 Sep; 34(4):458-66. PubMed ID: 25369441
[TBL] [Abstract][Full Text] [Related]
19. Autoimmune dementia and encephalopathy.
Flanagan EP; Drubach DA; Boeve BF
Handb Clin Neurol; 2016; 133():247-67. PubMed ID: 27112681
[TBL] [Abstract][Full Text] [Related]
20. Antibody-Mediated Autoimmune Encephalitis in Childhood.
Brenton JN; Goodkin HP
Pediatr Neurol; 2016 Jul; 60():13-23. PubMed ID: 27343023
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
